Investor, thanks for posting. Interesting that they start at 50mg doses and increase from there. Will be interesting to see how well tolerated this will be and any AE's.
their current trial incl. the quantitative EEG (global relative theta wave power) measure endpoint
W/luck they will see some kind of quantitative measure w/correlates to dose and cognition. Flashback to W.E. Deming..."If it cannot be measured, it cannot be managed.".